Kruppa A et al. |
Immediate reaction to roxithromycin and prick test cross-sensitization to erythromycin and clarithromycin. |
1998 |
Dermatology (Basel) |
pmid:9621142
|
Ishii K et al. |
Comparative study of pharmacokinetic parameters between clarithromycin and erythromycin stearate in relation to their physicochemical properties. |
1998 |
Drug Dev Ind Pharm |
pmid:15605442
|
van Westrhenen R et al. |
Pneumonia and glomerulonephritis caused by Mycoplasma pneumoniae. |
1998 |
Nephrol. Dial. Transplant. |
pmid:9870493
|
Waddell ST et al. |
Synthesis and antibacterial activity of O-methyl derivatives of azalide antibiotics: II. 6-OME derivatives via clarithromycin. |
1998 |
Bioorg. Med. Chem. Lett. |
pmid:9871759
|
Lee CL et al. |
One-week low-dose triple therapy is effective in treating Helicobacter pylori-infected patients with bleeding peptic ulcers. |
1998 |
J. Formos. Med. Assoc. |
pmid:9872028
|
Suzuki J et al. |
Relationship between the eradication of Helicobacter pylori and the healing pattern of peptic ulcer. |
1998 |
J. Clin. Gastroenterol. |
pmid:9872515
|
Sakaki N et al. |
Preliminary study on a novel quadruple eradication therapy with a mucoprotective drug, sofalcone, for Helicobacter pylori infection. |
1998 |
J. Clin. Gastroenterol. |
pmid:9872520
|
Yoshida Y et al. |
Discovery of a novel benzyloxyisoquinoline derivative with potent anti-Helicobacter pylori activity. |
1998 |
Bioorg. Med. Chem. Lett. |
pmid:9873455
|
Sakurai N et al. |
Synthesis and structure-activity relationships of 7-(2-aminoalkyl)morpholinoquinolones as anti-Helicobacter pylori agents. |
1998 |
Bioorg. Med. Chem. Lett. |
pmid:9873510
|
Komori T et al. |
Effect of clarithromycin on alpha1-acid glycoprotein levels in normal and diabetic rats. |
1998 |
Res. Commun. Mol. Pathol. Pharmacol. |
pmid:9874281
|
Kondoh K and Hashiba M |
[Inhibitory effect of macrolide antibiotics on biofilm formation by Pseudomonas aeruginosa]. |
1998 |
Nippon Jibiinkoka Gakkai Kaiho |
pmid:9493436
|
Mukunda BN et al. |
Clarithromycin therapy for bacillary peliosis did not prevent bacillary angiomatosis. |
1998 |
Clin. Infect. Dis. |
pmid:9770180
|
Stack WA et al. |
Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration. |
1998 |
Am. J. Gastroenterol. |
pmid:9772054
|
Adamek RJ and Bethke TD |
Cure of Helicobacter pylori infection and healing of duodenal ulcer: comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy. The International Pantoprazole HP Study Group. |
1998 |
Am. J. Gastroenterol. |
pmid:9772056
|
Stolte M et al. |
Cure of autoimmune gastritis by Helicobacter pylori eradication in a 21-year-old male. |
1998 |
Z Gastroenterol |
pmid:9773482
|
Pina M et al. |
Detection of point mutations associated with resistance of Helicobacter pylori to clarithromycin by hybridization in liquid phase. |
1998 |
J. Clin. Microbiol. |
pmid:9774580
|
Hawkey CJ et al. |
Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention. |
1998 |
Lancet |
pmid:9759744
|
Nelson KG et al. |
Results of operation in Mycobacterium avium-intracellulare lung disease. |
1998 |
Ann. Thorac. Surg. |
pmid:9725364
|
Sung JJ et al. |
One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9726384
|
Mégraud F and Doermann HP |
Clinical relevance of resistant strains of Helicobacter pylori: a review of current data. |
1998 |
Gut |
pmid:9764043
|
Pazzi P et al. |
Short-term low-dose pantoprazole-based triple therapy for cure of Helicobacter pylori infection in duodenal ulcer patients. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9726385
|
Heald AE et al. |
Taste and smell complaints in HIV-infected patients. |
1998 |
AIDS |
pmid:9764787
|
Harris AW et al. |
Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9726387
|
Perri F et al. |
Relationship between the results of pre-treatment urea breath test and efficacy of eradication of Helicobacter pylori infection. |
1998 |
Ital J Gastroenterol Hepatol |
pmid:9675647
|
Talley NJ et al. |
Nizatidine in combination with amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9678811
|
Hoppe JE and Bryskier A |
In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine). |
1998 |
Antimicrob. Agents Chemother. |
pmid:9559823
|
Ricciardiello L et al. |
Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9678812
|
Cammarota G et al. |
One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9678813
|
Louw JA et al. |
Two-week course of pantoprazole combined with 1 week of amoxycillin and clarithromycin is effective in Helicobacter pylori eradication and duodenal ulcer healing. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9678814
|
Kashuba AD and Amsden GW |
Bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9527816
|
Bocheńska-Marciniak M et al. |
[Clinical efficacy and safety of spiramycin and clarithromycin in the treatment of outpatients with lower respiratory tract infections]. |
1998 |
Pol. Arch. Med. Wewn. |
pmid:10335027
|
Casswall TH et al. |
One-week treatment with omeprazole, clarithromycin, and metronidazole in children with Helicobacter pylori infection. |
1998 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:9779970
|
Aberg JA et al. |
Eradication of AIDS-related disseminated mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy. |
1998 |
J. Infect. Dis. |
pmid:9780266
|
González Carro P et al. |
[Efficacy of an ultrashort protocol in the eradication of Helicobacter pylori]. |
1998 |
Rev Esp Enferm Dig |
pmid:9780793
|
Gangadharam PR |
Clarithromycin for non-mycobacterial diseases? |
1998 |
Int. J. Tuberc. Lung Dis. |
pmid:9783536
|
Hahn DL et al. |
Evidence for Chlamydia pneumoniae infection in steroid-dependent asthma. |
1998 |
Ann. Allergy Asthma Immunol. |
pmid:9475566
|
Sakamoto M et al. |
[Effect of clarithromycin treatment of natural killer cell activity in patients with advanced non-small cell lung cancer]. |
1998 |
Gan To Kagaku Ryoho |
pmid:9881083
|
Komori T et al. |
Effects of repeated clarithromycin administration on the pharmacokinetic properties of pindolol in rats. |
1998 |
Biol. Pharm. Bull. |
pmid:9881659
|
Shafran SD et al. |
Determinants of rifabutin-associated uveitis in patients treated with rifabutin, clarithromycin, and ethambutol for Mycobacterium avium complex bacteremia: a multivariate analysis. Canadian HIV Trials Network Protocol 010 Study Group. |
1998 |
J. Infect. Dis. |
pmid:9419201
|
van Aarem A et al. |
Recurrent therapy resistant mastoiditis by Mycobacterium cheilonae abscessus, a nontuberculous mycobacterium. |
1998 |
Int. J. Pediatr. Otorhinolaryngol. |
pmid:9596371
|
Koster F |
Paradoxical local response to therapy for Mycobacterium avium complex infection in four patients with AIDS. |
1998 |
Clin. Infect. Dis. |
pmid:9597260
|
Comet R et al. |
[Seven-day omeprazole, clarithromycin, and amoxicillin for the therapy of Helicobacter pylori infection]. |
1998 |
Gastroenterol Hepatol |
pmid:9549183
|
Carnicer J |
[Helicobacter pylori infection and recurrent abdominal pain in children. A proved relationship?]. |
1998 |
Gastroenterol Hepatol |
pmid:9549199
|
Iwata M et al. |
[Three cases of Fitz-Hugh-Curtis syndrome detected in the early stage by abdominal ultrasonography]. |
1998 |
Nippon Naika Gakkai Zasshi |
pmid:9549331
|
Rosina P et al. |
Fixed drug eruption from clarithromycin. |
1998 |
Contact Derm. |
pmid:9506224
|
Carlson LD et al. |
Standardized BACTEC method to measure clarithromycin susceptibility of Mycobacterium genavense. |
1998 |
J. Clin. Microbiol. |
pmid:9508306
|
Sato K et al. |
Antimicrobial activities of benzoxazinorifamycin KRM-1648, clarithromycin and levofloxacin against intracellular Mycobacterium avium complex phagocytosed by murine peritoneal macrophages. |
1998 |
J. Antimicrob. Chemother. |
pmid:9511040
|
Alegre Herrera S et al. |
[Clarithromycin-carbamazepine interaction: neurological symptoms and hyponatremia]. |
1998 |
An Med Interna |
pmid:9522506
|
Kaeser YA et al. |
Severe hypotension and bradycardia associated with verapamil and clarithromycin. |
1998 |
Am J Health Syst Pharm |
pmid:9825040
|
Hua J et al. |
Characterization of clinical isolates of Helicobacter pylori in Singapore. |
1998 |
Microbios |
pmid:9785486
|
Clark CL et al. |
Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologies. |
1998 |
J. Clin. Microbiol. |
pmid:9817876
|
Björkholm B et al. |
Rapid PCR detection of Helicobacter pylori-associated virulence and resistance genes directly from gastric biopsy material. |
1998 |
J. Clin. Microbiol. |
pmid:9817898
|
Arimori K et al. |
Characteristic difference in gastrointestinal excretion of clarithromycin and roxithromycin. |
1998 |
Biopharm Drug Dispos |
pmid:9818709
|
Sanfélix Genovés J et al. |
[Helicobacter pylori: 6-day triple therapy in duodenal ulcer]. |
1998 |
Aten Primaria |
pmid:9670578
|
Cirioni O et al. |
In-vitro activity of lytic peptides alone and in combination with macrolides and inhibitors of dihydrofolate reductase against Pneumocystis carinii. |
1998 |
J. Antimicrob. Chemother. |
pmid:9818742
|
de Boer WA et al. |
Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy. |
1998 |
Am. J. Gastroenterol. |
pmid:9672338
|
Vrioni G et al. |
Treatment of disseminated Mycobacterium genavense infection in a murine model with ciprofloxacin, amikacin, ethambutol, clarithromycin and rifabutin. |
1998 |
J. Antimicrob. Chemother. |
pmid:9818747
|
Martin SJ and Pendland SL |
Bactericidal activity and postantibiotic effect of clarithromycin and 14-hydroxyclarithromycin, alone and in combination, against Legionella pneumophila. |
1998 |
J. Antimicrob. Chemother. |
pmid:9687103
|
Hafner R et al. |
Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9517944
|
Fattorini L et al. |
Activities of isoniazid alone and in combination with other drugs against Mycobacterium avium infection in beige mice. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9517960
|
Trivedi S et al. |
Clarithromycin and digoxin toxicity. |
1998 |
Ann. Intern. Med. |
pmid:9518419
|
Laine L and Fendrick AM |
Helicobacter pylori and peptic ulcer disease. Bridging the gap between knowledge and treatment. |
1998 |
Postgrad Med |
pmid:9519040
|
Petersen AM et al. |
[Resistance of Helicobacter pylori to clarithomycin]. |
1998 |
Ugeskr. Laeg. |
pmid:9627511
|
Domingo D et al. |
High frequency of mutations at position 2144 of the 23S rRNA gene in clarithromycin-resistant Helicobacter pylori strains isolated in Spain. |
1998 |
J. Antimicrob. Chemother. |
pmid:9630414
|
Fireman Z et al. |
Helicobacter pylori and peptic ulcer disease therapies: a survey of gastroenterologists in Israel. |
1998 |
Helicobacter |
pmid:9631306
|
Battaglia G et al. |
Optimal PPI-based triple therapy for the cure of Helicobacter pylori infection: a single center comparison of four 14-day schedules. |
1998 |
Helicobacter |
pmid:9631310
|
Miwa H et al. |
Effectiveness of omeprazole-amoxicillin-clarithromycin (OAC) therapy for Helicobacter pylori infection in a Japanese population. |
1998 |
Helicobacter |
pmid:9631313
|
Calvet Calvo X |
[Treatment of Helicobacter pylori infections]. |
1998 |
Gastroenterol Hepatol |
pmid:9633184
|
Wang G et al. |
Genotypic characterization of clarithromycin-resistant and -susceptible Helicobacter pylori strains from the same patient demonstrates existence of two unrelated isolates. |
1998 |
J. Clin. Microbiol. |
pmid:9705423
|
van der Wouden EJ et al. |
One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial. |
1998 |
Am. J. Gastroenterol. |
pmid:9707042
|
Burman WJ et al. |
Long-term outcomes of treatment of Mycobacterium avium complex bacteremia using a clarithromycin-containing regimen. |
1998 |
AIDS |
pmid:9708410
|
Holmberg SD et al. |
Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. HIV Outpatient Study (HOPS) Investigators. |
1998 |
JAMA |
pmid:9459473
|
Dehesa M et al. |
[Comparison of 2 schedules based on pantoprazole for eradication of Helicobacter pylori in patients with active duodenal ulcer]. |
1998 Apr-Jun |
Rev Gastroenterol Mex |
pmid:10068730
|
Fennerty MB et al. |
A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori. |
1998 Aug 10-24 |
Arch. Intern. Med. |
pmid:9701099
|
Mikamo H et al. |
Effects of long-term/low-dose clarithromycin on neutrophil count and interleukin-8 level in pyometra. |
1998 Jan-Feb |
Chemotherapy |
pmid:9444409
|
Ziering W and McElvaine P |
Randomized comparison of once-daily ceftibuten and twice-daily clarithromycin in the treatment of acute exacerbation of chronic bronchitis. |
1998 Jan-Feb |
Infection |
pmid:9505188
|
Langan C et al. |
Short-course cefuroxime axetil therapy in the treatment of acute exacerbations of chronic bronchitis. |
1998 Jul-Aug |
Int. J. Clin. Pract. |
pmid:9796558
|
Habu Y et al. |
Triple therapy with omeprazole, amoxicillin and clarithromycin is effective against Helicobacter pylori infection in gastric ulcer patients as well as in duodenal ulcer patients. Results of a randomized controlled trial in Japan. |
1998 Jul-Aug |
Digestion |
pmid:9693202
|
Shafran SD |
Prevention and treatment of disseminated Mycobacterium avium complex infection in human immunodeficiency virus-infected individuals. |
1998 Jul-Sep |
Int. J. Infect. Dis. |
pmid:9831675
|
Venuta A et al. |
Azithromycin compared with clarithromycin for the treatment of streptococcal pharyngitis in children. |
1998 Jun-Jul |
J. Int. Med. Res. |
pmid:9718470
|
Fernández Bermejo M and GarcÃa Grávalos R |
[Ebrotidine in the eradicating treatment of H. pylori]. |
1998 Jun-Jul |
Gastroenterol Hepatol |
pmid:9711019
|
Oberg KC |
Delayed elevation of international normalized ratio with concurrent clarithromycin and warfarin therapy. |
1998 Mar-Apr |
Pharmacotherapy |
pmid:9545160
|
Vakil N |
Treatment of H. pylori infection: the reality. |
1998 Mar-Apr |
Yale J Biol Med |
pmid:10378357
|
Miehlke S et al. |
Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection. |
1998 Nov-Dec |
Digestion |
pmid:9813387
|
Adelglass J et al. |
A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis. |
1998 Nov-Dec |
Pharmacotherapy |
pmid:9855324
|
Tohnai A et al. |
Clarithromycin suppresses proliferation of rat nasal epithelium exposed to endotoxin. |
1998 Nov-Dec |
Am J Rhinol |
pmid:9883303
|
Mermelstein HT |
Clarithromycin-induced delirium in a general hospital. |
1998 Nov-Dec |
Psychosomatics |
pmid:9819955
|
Anzueto A et al. |
Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group. |
1998 Sep-Oct |
Clin Ther |
pmid:9829441
|
Kihira K et al. |
[Triple therapy regimens involving H2 blockaders for therapy of Helicobacter pylori infections]. |
1999 |
Nippon Rinsho |
pmid:10036953
|
Goto T et al. |
[Erosive duodenitis after eradication therapy for Helicobacter pylori]. |
1999 |
Nihon Shokakibyo Gakkai Zasshi |
pmid:10047687
|
Dionisio D et al. |
Encephalitis caused directly by Mycoplasma pneumoniae. |
1999 |
Scand. J. Infect. Dis. |
pmid:10576133
|
Yatsunami J et al. |
Roxithromycin and clarithromycin, 14-membered ring macrolides, potentiate the antitumor activity of cytotoxic agents against mouse B16 melanoma cells. |
1999 |
Cancer Lett. |
pmid:10660084
|
Catalano F et al. |
Comparative treatment of Helicobacter pylori-positive duodenal ulcer using pantoprazole at low and high doses versus omeprazole in triple therapy. |
1999 |
Helicobacter |
pmid:10469192
|
Yoshida Y et al. |
Synthesis and anti-Helicobacter pylori activity of FR182024, a new cephem derivative. |
1999 |
Bioorg. Med. Chem. Lett. |
pmid:10560737
|
Kamada T et al. |
Effect of smoking and histological gastritis severity on the rate of H. pylori eradication with omeprazole, amoxicillin, and clarithromycin. |
1999 |
Helicobacter |
pmid:10469195
|
Hewitt RG et al. |
Prevention of disseminated Mycobacterium avium complex infection with reduced dose clarithromycin in patients with advanced HIV disease. |
1999 |
AIDS |
pmid:10449290
|
Hoffman JS et al. |
Efficacy of a 1-week regimen of ranitidine bismuth citrate in combination with metronidazole and clarithromycin for Helicobacter pylori eradication. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10215735
|
Burgess DS et al. |
A time-kill evaluation of clarithromycin and azithromycin against two extracellular pathogens and the development of resistance. |
1999 |
Ann Pharmacother |
pmid:10630825
|
Xiao SD et al. |
High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102963
|
Yajima T et al. |
Optimum spray congealing conditions for masking the bitter taste of clarithromycin in wax matrix. |
1999 |
Chem. Pharm. Bull. |
pmid:10071855
|